Other OTC - Delayed Quote USD

Ampio Pharmaceuticals, Inc. (AMPE)

0.2200 0.0000 (0.00%)
At close: May 15 at 3:38 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Michael A. Martino CEO, CFO, General Secretary & Director 550k -- 1957
Dr. David Bar-Or M.D. Founder & Chairman of Scientific Advisory Board 145.6k -- 1949
April Ramirez Clinical Trial Manager -- -- --

Ampio Pharmaceuticals, Inc.

9800 Mount Pyramid Court
Suite 400
Englewood, CO 80112
United States
720 437 6500 https://ampiopharma.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
6

Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

Corporate Governance

Ampio Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 15, 2024
    15-12G: Notice of termination of registration of a class of securities under Section 12(g)
    See Full Filing
  • Apr 04, 2024
    25: Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
    See Full Filing
  • Mar 27, 2024
    10-K: Periodic Financial Reports
    See Full Filing
  • Mar 25, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Feb 28, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing

Upcoming Events

Aug 06, 2024 - Aug 12, 2024
Ampio Pharmaceuticals, Inc. Earnings Call

Related Tickers

BTTX Better Therapeutics, Inc.
0.0110
-26.17%
 
NAVB Navidea Biopharmaceuticals, Inc.
0.0250
-16.67%
 
ONCO Onconetix, Inc.
0.1116
+0.36%
 
CYTO Altamira Therapeutics Ltd.
1.5300
+4.08%
 
IMUC EOM Pharmaceuticals Holdings, Inc.
0.2100
0.00%
 
PSTV Plus Therapeutics, Inc.
2.3200
+6.91%
 
ATNF 180 Life Sciences Corp.
1.9400
-3.00%
 
PBM Psyence Biomedical Ltd.
0.8518
-2.02%
 
VRPX Virpax Pharmaceuticals, Inc.
0.7800
-65.64%
 
NYMXF Nymox Pharmaceutical Corporation
0.2001
-0.25%